4 Einträge von 4 mit therapies coding
clinicalodyssey.com
Datum der Indexierung 03.05.2024 22:10:10
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cells chimeric | cell genetic | malignant t-cells | plasma patient | multiple therapies | myeloma bcma | antigen these | against with | rrmm their | from clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
therapies, which utilize genetically modified T-cells from the same patient to find and destroy malignant cells carrying a specific molecule on their surface. CAR-T cell therapies against RRMM In CAR-T therapies, T-cells are obtained from patient blo coding for antibodies and include gene translocations from one chromosome to another or the gain of odd-numbered chromosomes. Patient survival is variable and usually dependent on the type of genetic aberration. The gain of odd-nu
Text Inhalt Text aus URL
Log Metriken 12445
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cells chimeric | cell genetic | malignant t-cells | plasma patient | multiple therapies | myeloma bcma | antigen these | against with | rrmm their | from clinical |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
therapies, which utilize genetically modified T-cells from the same patient to find and destroy malignant cells carrying a specific molecule on their surface. CAR-T cell therapies against RRMM In CAR-T therapies, T-cells are obtained from patient blo coding for antibodies and include gene translocations from one chromosome to another or the gain of odd-numbered chromosomes. Patient survival is variable and usually dependent on the type of genetic aberration. The gain of odd-nu
Text Inhalt Text aus URL
Log Metriken 12445
clinicalodyssey.com
Datum der Indexierung 03.05.2024 22:10:12
erkannte Namen Gene Therapy |
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cell medical | cells effects | receptor your | antigen region | chimeric about | b-cell therapy | clinical from | t-cell this | patient immunotherapy | lymphoma b-cells |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
therapies against B-cell lymphomas currently approved by the Food and Drug Administration (FDA) of the United States: axicabtagene ciloleucel, tisagenlecleucel, brexucabtagene autoleucel, and lisocabtagene maraleucel. In general, they are approved fo coding for the chimeric receptor. This receptor will be produced by infected T-cells and displayed on their surface. This treatment is usually administered intravenously. After patient delivery, T-cells containing the chimeric ant
Text Inhalt Text aus URL
Log Metriken 12446
erkannte Namen Gene Therapy |
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cell medical | cells effects | receptor your | antigen region | chimeric about | b-cell therapy | clinical from | t-cell this | patient immunotherapy | lymphoma b-cells |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
therapies against B-cell lymphomas currently approved by the Food and Drug Administration (FDA) of the United States: axicabtagene ciloleucel, tisagenlecleucel, brexucabtagene autoleucel, and lisocabtagene maraleucel. In general, they are approved fo coding for the chimeric receptor. This receptor will be produced by infected T-cells and displayed on their surface. This treatment is usually administered intravenously. After patient delivery, T-cells containing the chimeric ant
Text Inhalt Text aus URL
Log Metriken 12446
clinicalodyssey.com
Datum der Indexierung 03.05.2024 22:10:02
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords gene lack | retinal your | light particles | clinical reactions | therapy vision | that inherited | cells test | visual viral | patient protein | into this |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
therapies for other inherited retinal diseases, including retinitis pigmentosa, choroideremia, achromatopsia, and Leber’s hereditary optic neuropathy, are undergoing clinical trials. Inherited retinal diseases Inherited retinal diseases are a group o coding for the retinal pigment epithelium-specific 65 kDa (RPE65) protein. RPE65 and the visual cycle The RPE65 protein is an enzyme that plays an essential role in the visual cycle, a sequence of biochemical reactions in the reti
Text Inhalt Text aus URL
Log Metriken 12442
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords gene lack | retinal your | light particles | clinical reactions | therapy vision | that inherited | cells test | visual viral | patient protein | into this |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
therapies for other inherited retinal diseases, including retinitis pigmentosa, choroideremia, achromatopsia, and Leber’s hereditary optic neuropathy, are undergoing clinical trials. Inherited retinal diseases Inherited retinal diseases are a group o coding for the retinal pigment epithelium-specific 65 kDa (RPE65) protein. RPE65 and the visual cycle The RPE65 protein is an enzyme that plays an essential role in the visual cycle, a sequence of biochemical reactions in the reti
Text Inhalt Text aus URL
Log Metriken 12442
clinicalodyssey.com
Datum der Indexierung 03.05.2024 22:10:04
erkannte Namen Gene Therapy |
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cell marrow | cells bone | b-cell genetic | b-all have | receptor this | gene therapy | chimeric precursors | from patient | t-cells antigen | with these |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Therapies for B-ALL have historically included chemotherapy, neutralization with exogenous antibodies, and transplantation of hematopoietic stem cells. These treatments are associated with significant cell toxicity and high relapse rates, urging the coding for an anti-CD19 chimeric antigen receptor. After genetic modification and proliferation, T-cells are returned to the bloodstream of the patient. In the patient, these T-cells produce and display on their surface a chimeric
Text Inhalt Text aus URL
Log Metriken 12443
erkannte Namen Gene Therapy |
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords cell marrow | cells bone | b-cell genetic | b-all have | receptor this | gene therapy | chimeric precursors | from patient | t-cells antigen | with these |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Therapies for B-ALL have historically included chemotherapy, neutralization with exogenous antibodies, and transplantation of hematopoietic stem cells. These treatments are associated with significant cell toxicity and high relapse rates, urging the coding for an anti-CD19 chimeric antigen receptor. After genetic modification and proliferation, T-cells are returned to the bloodstream of the patient. In the patient, these T-cells produce and display on their surface a chimeric
Text Inhalt Text aus URL
Log Metriken 12443